Carlsmed, Inc. (CARL)

Market Cap	400.31M
Revenue (ttm)	38.27M
Net Income (ttm)	-26.20M
Shares Out	26.58M
EPS (ttm)	-6.13
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	177,740
Open	15.50
Previous Close	15.30
Day's Range	15.06 - 15.85
52-Week Range	11.81 - 15.85
Beta	n/a
Analysts	Strong Buy
Price Target	18.33 (+21.71%)
Earnings Date	Nov 14, 2025

About CARL

Carlsmed, Inc., a commercial-stage company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. The company develops aprevo, a comprehensive technology platform for spine fusion surgery procedures. Its aprevo platform includes proprietary surgical planning software, using outcomes-based algorithms that are aided with artificial intelligence, and resulting custom-built, anatomically designed vertebral interbody implants. The company was incorporated in 2018 and is based in Carlsbad, California.

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Jul 23, 2025
• Employees: 89
• Stock Exchange: NASDAQ
• Ticker Symbol: CARL
• Website: https://carlsmed.com

Analyst Summary

According to 3 analysts, the average rating for CARL stock is "Strong Buy." The 12-month stock price target is $18.33, which is an increase of 21.71% from the latest price.

Price Target

$18.33

(21.71% upside)

Analyst Consensus: Strong Buy